CETP inhibitor polypeptide, antibodies against the synthetic pol

Details CETP inhibitor polypeptide, antibodies against the synthetic pol CETP inhibitor polypeptide, antibodies against the synthetic pol

1994-02-08

1996-04-30

Warden, Jill

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

5303871, A61K 3514, C07K 100

Patent

active

055125484

ABSTRACT:
A polypeptide and analogues thereof inhibit cholesteryl ester transfer protein (CETP). An anti-atherosclerosis composition comprises an anti-atherosclerosis effective amount of the polypeptide and a pharmaceutically-acceptable carrier. An anti-atherosclerosis kit comprises in separate sterile containers at least one unit of the composition containing the polypeptide, one syringe and one needle. An antibody has specificity for the polypeptide of the invention, the baboon CETP 4kD polypeptide inhibitor, the 1-36 amino acid N-terminal fragment of apo C-I, modified apo A-I (MW:31kD) or modified apo E (MW:41kD). A method of preventing atherosclerosis in a mammal being predisposed to that condition comprises administering to the mammal a prophylactically effective amount of the polypeptide of the invention, and a method of treating a mammal afflicted with atherosclerosis comprises the administration of a therapeutically affective amount of the polypeptide disclosed herein.

REFERENCES:
Dolphin et al. Lipoprotein . . . programmers, Can. J. Cell Biol. 63:850-869, 1985.
Nishide et al., Inhibition . . . protein, J. Lipid Res, 30:149-158, 1989.
Keul et al., Expression . . . lipoprotein, 28:818-827, 1987.
Merrifield et al., The peptides, Analysis . . . Biology, vol. 2 Academic Press, 1980 pp. 1-284.
Lauer et al. Two . . . Gene, J. Biol. Chem., 263:7277-7286, 1988.
Harlow et al., Antibodies . . . Manual, p. 287, 1988.
Lerner et al., Antibodies . . . Medicine, Adv. Immunol. 36:1-44, 1984.
Koizumi et al., "Atherosclerosis", 58:175-186 (1985).
Yokoyama et al., "Artery" 14(1):43-51 (1986).
Kushwaha et al., "J. of Lipid Research", 31:965-973 (1990).
Son et al., "Biochhimica et Biophysica Acta", 795:473-480 (1984).
Kurasawa et al., "J. Biochem." 98:1499-1508 (1985).
Albers et al., "Lipids", 9:15-26 (1974).
Kohler et al., "Nature", 256:495-497 (1975).
Williams et al., "J. of Chromatography", 308:101-109 (1984).
Kushwaha et al., "J. of Lipid Research", 27:497-507 (1986).
McGill et al., "Arteriosclerosis", 6:651-663 (1986).
Redgrave et al., "Analytical Biochem.", 65:42-49 (1975).
Allain et al., "Clin. Chem.", 20:407-475 (1974).
Laemmli "Nature", 227:680-684 (1970).
Floren et al., "Metabolism", 30:367-375 (1981).
McKinney et al., "J. of Immunological Methods", 96:271-278 (1987).
Cheung et al., "J. of Lipid Research", 23:748-753 (1982).
Barany et al., "The Peptides", 2:1-284 (1980).
Duncan, D. B., "Biometrics", pp. 1-42 (1955).
Pearson et al., "Proc. Natl. Acad. Sci." 85:2444-2448 (1988).

Affiliated with

Also associated with

Rating

CETP inhibitor polypeptide, antibodies against the synthetic pol does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with CETP inhibitor polypeptide, antibodies against the synthetic pol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CETP inhibitor polypeptide, antibodies against the synthetic pol will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-628720